Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS
Content archived on 2024-06-12

Role of the angiopoietin system in tumor angiogenesis

Objective



Rescarch objectives and content
Tumors are usually not angiogenic at the beginning of their development. and conseauentely they remain limited to small volumes. The acquisition of the angiogenic activity depends on the balance of positive and negative angiogenic factors released by the tumors. The aim of this project is the identification and characterization of the molecular events that are involved in the onset of tumor angiognenesis. All the studies will be performed using as a model a transgenic mouse line expresses SV-1O large T-antigen (Tag) under the control of the rat insulin promoter (Rip1 Tag2). These mice develop tumors in the Lanoherans acells in a predictable manner and different stage of tumor progression are clearly distinguishable, thus, make them a valuable tool to study the molecular mechanism of tumor angiogenesis.Expression and functional studies of the TIE-2 receptor and its ligands angiopoietin-1 and angiopoietin-2 during tumor progression in Rip1Tag2 transgenic mice will be performed. The long term goal of the project is to determine the role of angiopoietins in tumor angiogenesis in vivo. In order to reach the aim we will generate transgenic mouse lines that overexpress angiopoietin-1 or anoiopoietin-2 specifically in the ,B cells under the control of the insulin promoter. In case the forced expression of angiopoietin has no impact on the development of islets of Langherans. these mouse lines will be crossed to Rip tag2 transgenic mice and potential effects on a cell tumorigenesis will be analyzed ..Training content (objective,benefit and expected impact) The aim of this project is the identification and characterization of the molecular events that are involved in the onset of tumor angiogenesis. In particular. I propose to investigate the functional role of TIE-2 receptor and its known ligands, angiopoietin-1 and angiopoietin-2. in tumor angiogenesis in RiplTag2 transgenic mice. Furthermore. I plan to use angiopoietin-1 and angiopoietin-2-specific probes toe identify and clone novel members of the angiopoietin family of growth factors. Links with industry/ / industrial relevance (22)

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

This project has not yet been classified with EuroSciVoc.
Be the first one to suggest relevant scientific fields and help us improve our classification service

You need to log in or register to use this function

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

Data not available

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

RGI - Research grants (individual fellowships)

Coordinator

FORSCHUNGSINSTITUT FUER MOLEKULARE PATHOLOGIE GMBH
EU contribution
No data
Address
Dr. Bohr-Gasse 7
1030 WIEN
Austria

See on map

Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data
My booklet 0 0